The Premier Bay Area Virology Event of the Year

Register Today!

Click Here to View the Video of the Event

CEND Internships Available

Interested in promoting science and awareness of infectious diseases?

Hack Day Success

Diagnostics by Design

Five Teams Compete in Diagnostics by Design Hack-a-thon

Now Open For Submissions

$15 Million Prize for Rapid Bacterial Clinical Diagnostics

Winning device will rule out antibiotic use or help identify an effective antibiotic to treat a patient

Want to stay connected?

Henry Wheeler Center for Emerging and Neglected Diseases (CEND)

The Henry Wheeler Center for Emerging & Neglected Diseases (CEND) was established as a multi-disciplinary research unit in 2008, with the support of a generous donation by Henry H. “Sam” Wheeler, Jr. The mission of CEND is to help the University of California, Berkeley make innovative and substantial contributions to the global response to emerging and neglected infectious diseases. We at CEND believe that by educating potential innovators, connecting researchers from diverse disciplines, and investing in research, we can help the best and brightest minds at UC Berkeley access the resources they need to make meaningful and innovative contributions to our scientific understanding and ability to combat emerging and neglected diseases.

Stories of Success

jay-keaslingOn April 11, 2013, the pharmaceutical company Sanofi launched the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today’s frontline anti-malaria drug based on Dr. Jay Keasling’s discovery at UC Berkeley.

To read more about this story, visit the UC Berkeley News Center.

More Stories

FEATURED VIDEO: Vaccination Gap: A panel discussion about the causes and consequences of undervaccination in California

Latest Videos

Videos from our past events are available in our video library.

TOP UA-36873340-1